NEW YORK, May 20, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that it has discovered a new financial statement syndrome, which was validated by comparing the pre-bankruptcy financial statements of Enron (Pink Sheets:ENRNQ), Sunbeam (Pink Sheets:SOCNQ) and scores of other companies. StockDiagnostics.com calls this early warning system, The EPS Syndrome(SM), and has filed patents on its discovery. StockDiagnostics.com has been publishing information on newly diagnosed and previously undetected or undiagnosed companies since March 8, 2002. Go to http://www.stockdiagnostics.com to find over 1,000 public companies that have been diagnosed with The EPS Syndrome.
One of the more recent companies that StockDiagnostics.com diagnosed and published on April 23, 2002 was Reliant Resources (NYSE:RRI). On May 8, 2002 Reliant announced its accounting irregularities, and has since seen its share price decline by approximately 50%. Had StockDiagnostics.com been publishing, Enron and Adelphia Communications (Nasdaq:ADLAE) would have been diagnosed with The EPS Syndrome, as early as May of 2001.
What is The EPS Syndrome?
The term The EPS Syndrome was chosen because the first of the criteria for the diagnosis is positive EPS (Earnings Per Share) for the quarter in which it was diagnosed. StockDiagnostics.com's patents pending formulas and technologies that screen for and identify The EPS Syndrome are based on a combination of different financial statement elements and ratios. The EPS Syndrome is diagnosed when the difference between a public company's OPS(SM) (Operational-cashflow Per Share) and its EPS (Earnings Per Share) reaches or exceeds a mathematical threshold or tolerance level. The primary catalyst for The EPS Syndrome diagnosis is negative OPS. Its detection triggers an extensive search for The EPS Syndrome. In order to be a candidate for the diagnosis of The EPS Syndrome, a public company must also exhibit certain financial statement criteria. The EPS Syndrome can only be diagnosed when all of the historic criteria and most recent (on diagnosis date) financial statement conditions have been met. The current and historic diagnoses of The EPS Syndrome are based upon a public company's quarterly financial reports.
For more information on The EPS Syndrome go to; http://www.stockdiagnostics.com/member/eps_syndrome.htm
For information on OPS (Operational-cashflow Per Share) go to; http://www.stockdiagnostics.com/member/ops.htm
For information on EPS (Earnings Per Share) go to; http://www.stockdiagnostics.com/eps.htm
About StockDiagnostic.com
StockDiagnostics.com has designed and built a proprietary data refinery that automates the process of collecting, sorting and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement and securities pricing variances or anomalies and to monitor changes in the performance of public companies.
For more information on StockDiagnostics.com go to; http://www.stockdiagnostics.com/member/help.htm#a1
Disclaimer:
The information provided by StockDiagnostics.com does not constitute a recommendation by StockDiagnostics.com to buy, sell or hold any security or to follow any particular trading or investment strategy. Also, the information provided should not be construed as, an offer, or a solicitation of an offer, to buy or sell securities. An Investor's best course of action must be based upon individual circumstances. StockDiagnostics.com shall not be liable for any damages or costs of any type arising out of, or in any way connected with, your use of our services.